by Sarah Moniz | Dec 19, 2017 | News, Thinking Out Loud -Blog
It all started in 2008, when Drs. Leslie and Annie De Groot, father and daughter, applied for a joint SBIR. Using their combined knowledge, as world leading endocrinologist and immunologist, they set out to develop a new way to treat Graves’ disease, an...
by Annie De Groot | Apr 25, 2017 | Featured, News, Thinking Out Loud -Blog
EpiVax Signs First Commercial License for Tregitope Technology PROVIDENCE, R.I., April 25, 2017 – Providence-based biotechnology company EpiVax, Inc. (“EpiVax”) has licensed its novel immune-modulating technology to an undisclosed global...
by Annie De Groot | Apr 7, 2017 | News
Providence, RI April 7th, 2017 Providence-based biotechnology company EpiVax, Inc. (“EpiVax”) has licensed its novel immune-modulating technology to an unnamed global pharmaceutical company, for use in autoimmune disease and allergy. Tregitopes, pronounced...
by Annie De Groot | Jan 10, 2014 | Thinking Out Loud -Blog
New EpiVax Publication: “Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?” December 2013, Vol. 9, No. 12 , Pages 1155-1157 Anne S De Groot EpiVax, Inc., 146 Clifford St, Providence, RI 02903,...